Singapore: Australian regenerative medicine firm, Orthocell, is looking ahead to raise $8 million through an Initial Pub...
One of the biggest challenges in developing and manufacturing antibodies is proving the equivalence or similarity to the...
Singapore: China Biologic Products, a plasma-based biopharmaceutical company in China, has marked sales growth of 6.2 pe...
Singapore: Australian regenerative drug company, Mesoblast, is planning to expand its global manufacturing base and the ...
Singapore: GE Healthcare has launched easy-to-use preparative system, ÄKTA start, for laboratory-scale protein purif...
Singapore: Roche has launched FLOW system, a user defined system for workflow chain from primary sample handling to qPCR...
Singapore: Ab Sciex, a global leader in analytical technologies, has unveiled three new solutions for biological researc...
Singapore: UK-based TAP Biosystems has appointed Australia's TrendBio, a company that supplies high quality life science...
Singapore: ProBioGen, a German contract development and manufacturing organization, has developed and implemented the Pa...
Singapore: US Food and Drug Administration (FDA) has approved Flucelvax (Influenza Virus Vaccine), the first cell-cultur...
Singapore: MedImmune, the global biologics arm of AstraZeneca, and WuXi AppTec, a leading research and development outs...
Singapore: BAC's partnership with GE Healthcare to develop innovative purification media for the production of novel typ...
US based Pelical BioThermal which is a global leader providing the broadcast and most innovative range of temperature-co...
